- Home
- CORT vs CFLT Comparison
CORT vs CFLT Comparison
Compare CORT & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- CFLT
- Stock Information
- Founded
- CORT 1998
- CFLT 2014
- Country
- CORT United States
- CFLT United States
- Employees
- CORT N/A
- CFLT N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- CFLT EDP Services
- Sector
- CORT Health Care
- CFLT Technology
- Exchange
- CORT Nasdaq
- CFLT Nasdaq
- Market Cap
- CORT 7.1B
- CFLT 8.1B
- IPO Year
- CORT N/A
- CFLT 2021
- Fundamental
- Price
- CORT $70.59
- CFLT $23.12
- Analyst Decision
- CORT Strong Buy
- CFLT Buy
- Analyst Count
- CORT 4
- CFLT 30
- Target Price
- CORT $142.00
- CFLT $31.00
- AVG Volume (30 Days)
- CORT 1.4M
- CFLT 6.8M
- Earning Date
- CORT 05-05-2025
- CFLT 04-30-2025
- Dividend Yield
- CORT N/A
- CFLT N/A
- EPS Growth
- CORT 8.36
- CFLT N/A
- EPS
- CORT 1.14
- CFLT N/A
- Revenue
- CORT $685,446,000.00
- CFLT $1,017,525,000.00
- Revenue This Year
- CORT $35.85
- CFLT $21.73
- Revenue Next Year
- CORT $35.22
- CFLT $18.93
- P/E Ratio
- CORT $61.82
- CFLT N/A
- Revenue Growth
- CORT 30.93
- CFLT 24.11
- 52 Week Low
- CORT $25.35
- CFLT $17.79
- 52 Week High
- CORT $117.33
- CFLT $37.90
- Technical
- Relative Strength Index (RSI)
- CORT 50.86
- CFLT 54.42
- Support Level
- CORT $69.33
- CFLT $20.46
- Resistance Level
- CORT $73.36
- CFLT $24.50
- Average True Range (ATR)
- CORT 3.66
- CFLT 1.09
- MACD
- CORT -0.20
- CFLT 0.29
- Stochastic Oscillator
- CORT 39.15
- CFLT 74.44
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About CFLT Confluent Inc.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.